Loading
ING1 (Inhibitor of growth protein 1) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Head and neck squamous cell carcinoma, Colorectal cancer and Endometrial cancer. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
Cooperates with p53/TP53 in the negative regulatory pathway of cell growth by modulating p53-dependent transcriptional activation. Implicated as a tumour suppressor gene. Location: Nucleus (UniProt). Locus 13q34 (HGNC).
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"ING1" OR ABSTRACT:"ING1" OR TITLE:"inhibitor of growth family member 1" OR ABSTRACT:"inhibitor of growth family member 1" OR TITLE:"Inhibitor of growth protein 1" OR ABSTRACT:"Inhibitor of growth protein 1" OR TITLE:"p33ING1" OR ABSTRACT:"p33ING1" OR TITLE:"p33ING1b" OR ABSTRACT:"p33ING1b" OR TITLE:"p24ING1c" OR ABSTRACT:"p24ING1c") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about ING1, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/ing1.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/ing1.json. Licence CC BY-NC 4.0.